Literature DB >> 7515100

The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line.

L M Karnitz1, S L Sutor, R T Abraham.   

Abstract

The proliferation of antigen-activated T cells is mediated by the T cell-derived growth factor, interleukin 2 (IL-2). The biochemical signaling cascades initiating IL-2-induced growth are dependent upon protein tyrosine kinase (PTK) activity. One IL-2-regulated PTK implicated in this cascade is the Src-family kinase, Fyn. Previous studies have described a physical association between Fyn and a potential downstream substrate, phosphatidylinositol 3-kinase (PI3-kinase) as well as the IL-2-dependent activation of PI3-kinase in T cells; however, the role of Fyn in IL-2-induced PI3-kinase activation remains unclear. In this report, we demonstrate that IL-2 stimulation triggers tyrosine phosphorylation of the p85 subunit of PI3-kinase in the murine T cell line, CTLL-2. Lysates prepared from growth factor-deprived and IL-2-stimulated T cells reconstituted both the binding of CTLL-2 cell-derived Fyn to and the IL-2-inducible tyrosine phosphorylation of exogenously added recombinant p85. Furthermore, overexpression of wild-type Fyn in these cells enhanced both the basal and IL-2-mediated activation of PI3-kinase. Additional studies of the Fyn-PI3-kinase interaction demonstrated that the Src homology 3 (SH3) domain of Fyn constitutes a direct binding site for the p85 subunit of PI3-kinase. These results support the notion that Fyn may be directly involved in the activation of the downstream signaling enzyme, PI3-kinase, in IL-2-stimulated T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515100      PMCID: PMC2191517          DOI: 10.1084/jem.179.6.1799

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

Review 1.  Regulation of lymphocyte function by protein phosphorylation.

Authors:  R M Perlmutter; S D Levin; M W Appleby; S J Anderson; J Alberola-Ila
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 2.  The IL-2/IL-2 receptor system: a current overview.

Authors:  T Taniguchi; Y Minami
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

3.  The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain.

Authors:  A S Shaw; K E Amrein; C Hammond; D F Stern; B M Sefton; J K Rose
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

4.  Protein tyrosine phosphorylation associated with activation of the interleukin 2 receptor.

Authors:  I Merida; G N Gaulton
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

5.  The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells.

Authors:  D Heffetz; I Bushkin; R Dror; Y Zick
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

6.  A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization.

Authors:  M Hatakeyama; H Mori; T Doi; T Taniguchi
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  Differential effects of interleukin-2 and interleukin-4 on protein tyrosine phosphorylation in factor-dependent murine T cells.

Authors:  J A Augustine; J W Schlager; R T Abraham
Journal:  Biochim Biophys Acta       Date:  1990-05-02

8.  The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation.

Authors:  I Merida; P Williamson; W A Kuziel; W C Greene; G N Gaulton
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

9.  Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2.

Authors:  E M Saltzman; R R Thom; J E Casnellie
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

10.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen.

Authors:  H MacArthur; G Walter
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  19 in total

1.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

Authors:  M L Boytim; P Lilly; K Drouvalakis; S C Lyu; R Jung; A M Krensky; C Clayberger
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

3.  Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.

Authors:  Y Kubota; T Tanaka; A Kitanaka; H Ohnishi; Y Okutani; M Waki; T Ishida; H Kamano
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  Role of Fyn and PI3K in H2O2-induced inhibition of apical Cl-/OH- exchange activity in human intestinal epithelial cells.

Authors:  Seema Saksena; Ravinder K Gill; Sangeeta Tyagi; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Biochem J       Date:  2008-11-15       Impact factor: 3.857

Review 5.  IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.

Authors:  K S Zier; B Gansbacher
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

Review 6.  Common gamma chain cytokines in combinatorial immune strategies against cancer.

Authors:  Stephanie R Pulliam; Roman V Uzhachenko; Samuel E Adunyah; Anil Shanker
Journal:  Immunol Lett       Date:  2015-11-17       Impact factor: 3.685

7.  Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.

Authors:  L M Karnitz; L A Burns; S L Sutor; J Blenis; R T Abraham
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

Authors:  D Mahadevan; E G Chiorean; W B Harris; D D Von Hoff; A Stejskal-Barnett; W Qi; S P Anthony; A E Younger; D M Rensvold; F Cordova; C F Shelton; M D Becker; J R Garlich; D L Durden; R K Ramanathan
Journal:  Eur J Cancer       Date:  2012-08-23       Impact factor: 9.162

9.  IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.

Authors:  Hai-Hui Xue; Panu E Kovanen; Cynthia A Pise-Masison; Maria Berg; Michael F Radovich; John N Brady; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-27       Impact factor: 11.205

10.  Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.

Authors:  S A Barker; K K Caldwell; A Hall; A M Martinez; J R Pfeiffer; J M Oliver; B S Wilson
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.